In this GEN webinar, we will learn current methodology for using Micro-Flow Imaging (MFI) to assess size and agglomeration of PLGA microparticles—since MFI is able to differentiate between fines, ...

Dynamic Image Analysis directly addresses micro-flow imaging’s inherent scalability and workflow limitations. Both ...

Have you met MFI? Micro-flow imaging is a new solution for measuring and visualizing subvisible particles in biopharmaceutical products. As these small (1-1,000 micron) particles are considered a ...

Strategies for monitoring subvisible particles in biopharmaceutical formulations are central to developing and manufacturing safe, effective drug products. This webinar will introduce flow imaging ...

This past spring, the U.S. Pharmacopeia indicated that it was considering new guidelines for the determination of particulate matter in therapeutic formulations. Existing guidelines emphasize the use ...

In 2016, the FDA identified particulate matter contamination as the second leading cause of product recalls. Current contaminant detection techniques, such as light obscuration (LO), are restricted in ...

Locard’s exchange principle, which states that “every contact leaves a trace” drives the concept of “trace evidence” in the forensic sciences. Trace evidence is usually classed as fine particles, ...

Laser Speckle Imaging (LSI) has emerged as a pivotal optical technique in the non‐invasive visualisation and quantification of blood flow dynamics. By analysing the interference pattern generated when ...